Trial Profile
Pantoprazole and omeprazole as components of first line triple therapy in patients with helicobacter pylori infections receiving clarithromycin and amoxicillin.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 25 Feb 2011
Price :
$35
*
At a glance
- Drugs Pantoprazole (Primary) ; Amoxicillin; Clarithromycin; Esomeprazole; Omeprazole
- Indications Helicobacter pylori infections
- Focus Therapeutic Use
- 05 Jul 2010 New trial record
- 01 May 2010 Interim results in 232 patients were reported at the Digestive Disease Week 2010.